Topical diclofenac usage among Medicare beneficiaries rose 1621% (2015-2019) independent of marketing, potentially reflecting therapeutic substitution driven by national efforts to reduce opioid prescribing.
David Powell, PhD
Advertisement
Articles by David Powell, PhD
Advertisement
Latest Updated Articles
Rapid Increase in Topical Diclofenac Use for Chronic Pain, 2011-2020October 27th 2026
Advertisement
Advertisement
Trending on AJMC
1
Four Major Idiopathic Pulmonary Fibrosis Advances From 2026
2
Elagolix Noninferior to Dienogest for Endometriosis Pain in Phase 3 Trial
3
5 Things to Know About HHS's Interim Peptide Compounding Policy
4
HHS Draft Policy Eases Enforcement on 6 Compounded Peptides
5